IOBT — IO Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- $93.55m
- -$49.64m
Annual cashflow statement for IO Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -10.7 | -12 | -67.9 | -71.5 | -86.1 |
| Depreciation | |||||
| Non-Cash Items | 0.959 | 1.94 | 28 | 7.39 | 8.27 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.893 | 0.148 | -0.776 | 4.24 | 5.87 |
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -8.89 | -9.96 | -40.6 | -59.7 | -71.7 |
| Capital Expenditures | — | — | -0.153 | -0.69 | -0.323 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | — | -0.153 | -0.69 | -0.323 |
| Financing Cash Flow Items | 0 | -0.014 | -12.1 | 0 | -3.2 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.01 | 5.1 | 253 | 0 | 71.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.125 | -4.44 | 208 | -68.9 | 0.603 |